Clinical Trial Update: GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease [Phase 3]

View source ↗

Summary

Phase 3 trial update for GSK1605786A in maintenance of remission for Crohn's disease; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• GSK1605786A

Snippet

Sponsor: GlaxoSmithKline | Conditions: Crohn's Disease | Phase 3 | Status: TERMINATED | Results posted: 2017-09-07